Literature DB >> 16966431

Primary glioblastomas express mesenchymal stem-like properties.

Cho-Lea Tso1, Peter Shintaku, James Chen, Qinghai Liu, Jason Liu, Zugen Chen, Koji Yoshimoto, Paul S Mischel, Timothy F Cloughesy, Linda M Liau, Stanley F Nelson.   

Abstract

Glioblastoma is the most common and aggressive primary brain cancer. Recent isolation and characterization of brain tumor-initiating cells supports the concept that transformed neural stem cells may seed glioblastoma. We previously identified a wide array of mesenchymal tissue transcripts overexpressed in a broad set of primary glioblastoma (de novo) tumors but not in secondary glioblastoma (derived from lower-grade) tumors, low-grade astrocytomas, or normal brain tissues. Here, we extend this observation and show that a subset of primary glioblastoma tumors and their derived tumor lines express cellular and molecular markers that are associated with mesenchymal stem cells (MSC) and that glioblastoma cell cultures can be induced to differentiate into multiple mesenchymal lineage-like cell types. These findings suggest either that a subset of primary glioblastomas derive from transformed stem cells containing MSC-like properties and retain partial phenotypic aspects of a MSC nature in tumors or that glioblastomas activate a series of genes that result in mesenchymal properties of the cancer cells to effect sustained tumor growth and malignant progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966431     DOI: 10.1158/1541-7786.MCR-06-0005

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  105 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 2.  New promising drug targets in cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2010-03-23       Impact factor: 7.851

Review 3.  Integration and analysis of genome-scale data from gliomas.

Authors:  Gregory Riddick; Howard A Fine
Journal:  Nat Rev Neurol       Date:  2011-07-05       Impact factor: 42.937

4.  Neural stem cells and glioblastoma.

Authors:  Rossella Rispoli; Carlo Conti; Paolo Celli; Emanuela Caroli; Sandro Carletti
Journal:  Neuroradiol J       Date:  2014-04-18

Review 5.  The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.

Authors:  Estelle Willems; Arnaud Lombard; Matthias Dedobbeleer; Nicolas Goffart; Bernard Rogister
Journal:  Target Oncol       Date:  2017-02       Impact factor: 4.493

6.  Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.

Authors:  Simon Lord-Dufour; Ian B Copland; Louis-Charles Levros; Martin Post; Abhirup Das; Chaitan Khosla; Jacques Galipeau; Eric Rassart; Borhane Annabi
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

7.  Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.

Authors:  Xinlong Ma; Koji Yoshimoto; Yaulei Guan; Nobuhiro Hata; Masahiro Mizoguchi; Noriaki Sagata; Hideki Murata; Daisuke Kuga; Toshiyuki Amano; Akira Nakamizo; Tomio Sasaki
Journal:  Neuro Oncol       Date:  2012-07-27       Impact factor: 12.300

Review 8.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

9.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.

Authors:  Qinghai Liu; David H Nguyen; Qinghua Dong; Peter Shitaku; Kenneth Chung; On Ying Liu; Jonathan L Tso; Jason Y Liu; Veerauo Konkankit; Timothy F Cloughesy; Paul S Mischel; Timothy F Lane; Linda M Liau; Stanley F Nelson; Cho-Lea Tso
Journal:  J Neurooncol       Date:  2009-05-26       Impact factor: 4.130

10.  Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.

Authors:  Sonja Mertsch; Leon J Schurgers; Kathrin Weber; Werner Paulus; Volker Senner
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.